Lisanti Capital Growth, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Lisanti Capital Growth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $1.34 Million - $2.36 Million	-33,765 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$58.09 - $82.51 $1.96 Million - $2.79 Million	33,765 New	33,765 $2.24 Million
Q3 2021 Nov 03, 2021	SELL	$58.38 - $84.96 $4.77 Million - $6.95 Million	-81,770 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $5.08 Million - $7.39 Million	81,770 New	81,770 $6.77 Million
Q1 2021 May 12, 2021	SELL	$61.35 - $90.47 $6.38 Million - $9.4 Million	-103,955 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$43.82 - $85.37 $4.56 Million - $8.87 Million	103,955 New	103,955 $7.98 Million
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $210,020 - $644,770	-10,215 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $287,450 - $745,797	10,215 New	10,215 $648,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.